BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19517314)

  • 1. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 2. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract]   [Full Text] [Related]  

  • 3. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
    Bodovitz S
    IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery on Target 2006 - CHI's fourth annual event. Chemogenomics: small molecules as biological probes.
    Murphy M
    IDrugs; 2007 Jan; 10(1):30-2. PubMed ID: 17187311
    [No Abstract]   [Full Text] [Related]  

  • 5. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 6. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
    Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
    J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular Diseases & Drug Discovery--GTCbio's Inaugural Conference. 20-21 April 2009, Philadelphia, PA, USA.
    Boniuk V
    IDrugs; 2009 Jun; 12(6):346-8. PubMed ID: 19517312
    [No Abstract]   [Full Text] [Related]  

  • 10. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug discovery and the medicinal chemist.
    Maryanoff BE
    Future Med Chem; 2009 Apr; 1(1):11-5. PubMed ID: 21426067
    [No Abstract]   [Full Text] [Related]  

  • 14. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro- and nanofluidic systems for high-throughput biological screening.
    Hong J; Edel JB; deMello AJ
    Drug Discov Today; 2009 Feb; 14(3-4):134-46. PubMed ID: 18983933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two 'Golden Ratio' indices in fragment-based drug discovery.
    Orita M; Ohno K; Niimi T
    Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
    Marblestone JG
    IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cambridge Healthtech Institute Drug Discovery Chemistry. San Diego, CA, USA, 12-14 April, 2011.
    Sherman W; Salam N; Warshaviak D
    Future Med Chem; 2011 Sep; 3(12):1465-7. PubMed ID: 21882939
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH; Macarron R
    Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.